chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 16 year old female who, on approximately 16-JUL-2007 was vaccinated with a second dose of Gardasil. Subsequently, the patient experienced pain in shoulder that lasted for about a week after the vaccination. It was reported that the patient did not experienced pain when she received the first dose of the vaccination. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022; No adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022).    Concomitant medication information was not provided by the reporter.  Patient had received half dose of the vaccine.   Vial was initially stored in refrigerator on 04-Jun-2022. Temperature excursion issue not occurred with the product.  Treatment information was not provided by the reporter.
It was reported that an 83 year old female patient received a Fluzone SV '01-'02 vaccination, given IM in the left deltoid and a Pneumococcal vaccination given IM in the right deltoid on 11/02/01. Reportedly, on 11/03/01,the patient developed a band rash around her left arm that was red and hot to the touch. The patient reportedly recovered from this experience.
Approx 8-10 minutes after receiving FLUZONE became diaphoretic, complained of "trouble swallowing" and elevated B/P. Received BENADRYL 25 mg po and Epinephrine 1:1000 .3 mL SQ (Lt) arm. Within 7 minutes symptoms improved (after BENADRYL and Epinephrine). No other complaints.
Patient has ongoing nausea vomiting for 4 days needing hosp stay for IVF IV anti-emetics
Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point; Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point) and PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022 at 6:09 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 19-Jan-2022 at 6:09 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point) and PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired, 5 doses had been given at that point) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  On 16-Dec-2021 vial was initially stored in the refrigerator. The Moderna Covid-19 Vaccine was given past the beyond use date of 15-Jan-2022, it was brought to attention on 26 Jan 2022. Patient was notified of the error and patient denied any adverse effects.  Treatment information was not provided.
Vaccination administered was expired. Patient had not experienced any symptoms and will return to the pharmacy for re-vaccination today.
Arm pain in R side (where HPV was received) persistent beyond typical time frame. Was seen in clinic on 10/31 for this continued pain. Causing difficulty sleeping on R side. Difficulty with playing at recess (football). Other injection site pain on L arm resolved weeks ago. No redness/swelling/cyst noted to R arm. Full range of motion. Pain at it's worst when arms extended overhead. Pain with palpation of deltoid muscle, about 4-5 inches below acromion process
Extreme ache at injection site; gastrointestinal discomfort; fever; tachycardia.
lost the sense of smell; sore throat; chills; headaches; body aches; tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID-19), ANOSMIA (lost the sense of smell), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills) and HEADACHE (headaches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical reported history provided by the reporter.  Concomitant products included OMEPRAZOLE and PARACETAMOL (TYLENOL) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills), HEADACHE (headaches) and MYALGIA (body aches). On 20-Mar-2021, the patient experienced ANOSMIA (lost the sense of smell). On 02-Apr-2021, SARS-COV-2 TEST POSITIVE (tested positive for COVID-19), ANOSMIA (lost the sense of smell), OROPHARYNGEAL PAIN (sore throat), CHILLS (chills), HEADACHE (headaches) and MYALGIA (body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: positive (Positive) Became COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medicine. treatment(symptomatic) include cough syrup.  It was reported that the patient I would like to be able to receive the second dose of the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow-up information received on 13-May 2021, patient details updated, event outcome updated.
Local leg swelling, warmth, redness within 1 day of vaccination, worsened 48hrs after vaccination then improving by day 4 after vaccination. Swelling and redness measured 8 inches x 5.25 inches in office 48hrs after vaccination
approx 48hr p/vax pt begin to have throbbing pain in upper arm;
?COVID Arm?  Raised bump at injection site about 3.5? diameter, hard large lump, itchy and skin numb at site for 6 days, lessening in density, itchiness and size thereafter.
Body ache at the start as all through Headache all day the second day Fever bad the night of shot Nausea started the night of the shot and continued to next day Tiredness on day two  Just took Advil as treatment
Headache; Hypertension; Face flushed; Extremely tired; Slow Motion; Slurred Speech; This is a spontaneous report from a contactable healthcare professional. A 38-year-old female patient started to receive BNT162B2 (lot number: EJ1685), intramuscularly on 29Dec2020 08:00 at left arm at single dose for COVID-19 immunization. Medical history included hypertension. Concomitant medications were not reported. Patient previously took metronidazole (FLAGYL) and experienced allergy. Patient experienced headache, hypertension, face flushed, extremely tired, slow motion, and slurred speech on 29Dec2020 09:30. Treatment was not received for these events. Outcome of the events was resolving.
Chills, fever 101.5 degree, vomiting, red spot at injection site the size of a 50 cent piece.
This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (was eating and had to leave the food in the middle,), ABDOMINAL DISCOMFORT (upset stomach), DIZZINESS (dizziness , that lasted for 2 or 3 days), FLATULENCE (has foul-smelling flatulence even though she is eating her regular food, ¨had never experienced this before.) and FEELING ABNORMAL (Since she got the vaccine, her ¨body is different , it is not the same one', some days she is fine and others that she fells horrible, it has been 2 weeks and i am feeling uncomfortable) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Surgery (Patient had surgery "for not getting pregnant") in 2016. On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach) and FEELING ABNORMAL (Since she got the vaccine, her ¨body is different , it is not the same one', some days she is fine and others that she fells horrible, it has been 2 weeks and i am feeling uncomfortable). On 07-May-2021, the patient experienced DIZZINESS (dizziness , that lasted for 2 or 3 days), NAUSEA (nauseas that lasted for 2 or 3 days, has nauseas, everything she smells make her felt with nauseas), PYREXIA (fever, that lasted for 2 or 3 days) and HEADACHE (headache, that lasted for 2 or 3 days). In May 2021, the patient experienced FLATULENCE (has foul-smelling flatulence even though she is eating her regular food, ¨had never experienced this before.). On 23-May-2021, the patient experienced DECREASED APPETITE (was eating and had to leave the food in the middle,). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (was eating and had to leave the food in the middle,), ABDOMINAL DISCOMFORT (upset stomach), DIZZINESS (dizziness , that lasted for 2 or 3 days), FLATULENCE (has foul-smelling flatulence even though she is eating her regular food, ¨had never experienced this before.), FEELING ABNORMAL (Since she got the vaccine, her ¨body is different , it is not the same one', some days she is fine and others that she fells horrible, it has been 2 weeks and i am feeling uncomfortable), NAUSEA (nauseas that lasted for 2 or 3 days, has nauseas, everything she smells make her felt with nauseas), PYREXIA (fever, that lasted for 2 or 3 days) and HEADACHE (headache, that lasted for 2 or 3 days) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided.
various other symptoms; fever; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (various other symptoms) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (various other symptoms) and PYREXIA (fever). At the time of the report, ADVERSE EVENT (various other symptoms) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
2 days after first dose a lump on collar bone on injection side developed which is about 1/2 inch diameter and has stayed the same size but not went away.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, diverticulosis, early glaucoma and joint pain. The patient did not have any allergies to medications, food, or other products. Concomitant medication included hydroxychloroquine (MANUFACTURER UNKNOWN), naproxen (NAPROXENE), diclofenac (VOLTAREN), acetylsalicylic acid, ascorbic acid (ASPIRIN); all since unknown dates and for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Feb2021 after two days of vaccination, the patient experienced a lump on collar bone on injection side developed which is about half inch diameter and had stayed the same size but not went away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lump on collar bone on injection side was not recovered, at this time of report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5206,) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional (nurse) and described the occurrence of extensive swelling of vaccinated limb in a 45-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 24 September 2013 the subject received 1st dose of FLUARIX (.5 ml, unknown route, right deltoid). On 24 September 2013, less than one day after vaccination with FLUARIX, the subject experienced extensive swelling of vaccinated limb, injection site redness, injection site pain and injection site warmth (described as fever on right arm). The nurse reported that the edema on the subject's right arm at the injection site was 4 inches by 3 inches in size (75 by 101.6 millimeters). The nurse reported that the injection site pain as "pain, achy." At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with FLUARIX. Follow-up information was received on 01 November 2013 via healthcare professional who reported the subject received FLUARIX via subcutaneous injection on 24 September 2013 and experienced an additional event of intramuscular formulation administered by other route. The healthcare professional did not attribute the events to medical history/ concurrent illness, lack of efficacy, erroneous administration or suspected transmission of an infectious agent via medicinal product, and considered the events not serious. On 1 October 2013, the extensive swelling of vaccinated limb, injection site redness, injection site pain and injection site warmth were resolved.
Day after got vaccine, Td, arm where vaccine was given right arm c/o very painful, difficulty moving arm, area red and swollen, hard, next day arm was improving.
Feeling of sensitivity at vaccine site; occasional burning sensation at vaccine site.  February 2010, began to feel muscle achiness, arm heaviness, more pain in tissue under vaccine site.  Sought medical attention 2/16/2010.  No treatment.  Suggested waiting additional 1-2 months to see if it goes away.
tonic-clonic gen sz;2min duration;SMA 7 WNL, CT scan WNL, EEG pending;no tx
lymph gland painful on the arm pit; My body was frozen; Muscular pain injection site - right arm; starting to be sleepier than usual; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (starting to be sleepier than usual), FEELING COLD (My body was frozen), INJECTION SITE PAIN (Muscular pain injection site - right arm) and AXILLARY PAIN (lymph gland painful on the arm pit) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (left hand two fingures).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HYPERSOMNIA (starting to be sleepier than usual) and INJECTION SITE PAIN (Muscular pain injection site - right arm). On 30-Jan-2021, the patient experienced FEELING COLD (My body was frozen). On 03-Feb-2021, the patient experienced AXILLARY PAIN (lymph gland painful on the arm pit). On 31-Jan-2021, INJECTION SITE PAIN (Muscular pain injection site - right arm) had resolved. On 04-Feb-2021, AXILLARY PAIN (lymph gland painful on the arm pit) had resolved. On 06-Feb-2021, HYPERSOMNIA (starting to be sleepier than usual) and FEELING COLD (My body was frozen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Heart rate: 126 beats/min (High) 126 beats/min.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 30-Jan-2021, the patient's body temperature was 98.4 and she was wearing a watch vivo fit 4, it shows extreme heart beat of 126 beats/min. On 06-Feb-2021, all the symptoms were gone except for the heart beat still monitoring it. On 12-Jan-2021, the patient was given antibiotics after surgery for 7 days. Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Follow up received included no new significant information
Approximately 2 hours after vaccine started to get foggy and dizzy. As time went on around 5 hours after the vaccine I got severly nauseous with a headache and general weakness. Slight blurred vision and general unsteadiness on my feet. Along with aches in neck and shoulders. Currently I have sought no treatment and the symptoms as of 937pm on April 17th have begun to dissipate with the exception of weakness, tiredness, confusion, and a little nausea
24 hrs after vaccination purpura, Buttock & arms with mild prolonged P.T. Sibling vaccinated as well with similar clinical uresqulation, may be Henoch-Schonlein Purpura.
10/18 got flu shot, next few days, increasing redness. 10/21 mom saw 1st time max tenderness, 4" oval concentric circles on thigh, 1" central knot/nodule seen in clinic 10/22 slight decreased erythema, limping. 10/23 resolving with itch.
Information has been from a health professional referring to a 6 month old female patient. On 24-JUL-2015 10:00 AM, the patient was vaccinated with oral, ROTATEQ (dose 3, lot number K0023157 is an invalid lot number, oral, however, Lot number K023157 is valid, dose unknown) orally, which was exposed to temperatures outside of the recommended range. Concomitant therapies included PREVNAR and PEDIARIX. No adverse effects were reported. This is of several reports received from the same reporter. Additional information is not expected because reported follow up information has already been received.
The fist size rash is sore to the touch; Fist size rash red and itchy rash/ fist size rash is sore to the touch and itches a lot.; Red and itchy rash; This spontaneous case was reported by a patient and describes the occurrence of TENDERNESS (The fist size rash is sore to the touch), RASH PRURITIC (Fist size rash red and itchy rash/ fist size rash is sore to the touch and itches a lot.) and RASH ERYTHEMATOUS (Red and itchy rash) in a 57-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 06-Nov-2022, the patient experienced TENDERNESS (The fist size rash is sore to the touch), RASH PRURITIC (Fist size rash red and itchy rash/ fist size rash is sore to the touch and itches a lot.) and RASH ERYTHEMATOUS (Red and itchy rash). At the time of the report, TENDERNESS (The fist size rash is sore to the touch), RASH PRURITIC (Fist size rash red and itchy rash/ fist size rash is sore to the touch and itches a lot.) and RASH ERYTHEMATOUS (Red and itchy rash) outcome was unknown.            Concomitant products were not reported.  It was reported that patient received previous all doses from Moderna vaccines but did not had lot numbers with her. This was her second booster, the last one was in Jan-2022.  Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Nov-2022: Live follow-up significant information received: reporter information, patient information, vaccination date and event onset updated.
Nausea R11.0: Pt with nausea, vomiting, and diarrhea beginning around 7pm on 20 September 2017. Tachycardic from dehydration so given 1L bolus NS. Given Zofran 4mg ODT X1 from ED as well as 4 day supply r for nausea. Spoke with Allergy/Immunologist about case and given that this pt has had this vaccine before and tolerated well, as well as no cutaneous findings, does not recommend to stop giving the anthrax vaccine at this time. Likely a gastroenteritis. Pt given return precautions. -zofran 4mg ODT X4 days -zofran 4mg X1 from in ED -1L NS.
Pt had bloody diarrhea following his imms-visit on 11/2/15. No significant stomach discomfort small amount of blood in diaper to start with that changed to bloody diarrhea. Lasted x 2 days.
On 01-24-2021, Sunday afternoon, I experienced soreness to my left arm and a knot-like sensation that was hot upon palpation. I went to an urgent care but they did not do anything for me and was discharged home. On Tuesday 01-27-2021, went to another urgent care and I was told I had "Covid arm" due to the redness in my arm at the injection site.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions and concomitant medications were unknown. On 08-JAN-2016, the patient was vaccinated with first dose of M-M-R II, VARIVAX  and VAQTA (Merck). On 28-APR-2016 the patient was vaccinated with second doses of M-M-R II lot # L026553 expiry date 16-JUL-2017, VARIVAX (Merck) lot # L0423622 expiry date 03-NOV-2017 and VAQTA lot # L045713 expiry date 14-JAN-2017 earlier than recommended dosing schedule. Additional information has been requested.